In another study that included a more heterogeneous population of patients with hematological malignancies, the strong correlation between CD19+ B cells and serological response was confirmed, and there was no correlation between antibody concentration and CD4+ or CD8+ T cells [39]. Here, CD8A is linked to hematologic disorder.